跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Rabesta
Approved
STANDARD
Rabesta
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fc992dff736a52db
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
fc992dff736a52db
Drug Approval Philippines Name
Rabesta
Product Name
Rabesta
Registration Number
DRP-6763
Brand Name
Rabesta
Generic Name
Rabeprazole Sodium
Dosage Form
Powder for Solution for Intravenous Injection
Dosage Strength
20 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambicare Pharmaceuticals Inc.
Issuance Date
26 May 2021
Expiry Date
20 July 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fc992dff736a52db
Type
Standard
Back to Philippines FDA Approvals
Rabesta - Philippines FDA Drug Approval Details